Author

Diane M. Hargrove

Observed names: Diane Hargrove, Diane M Hargrove

Institution: Ferring Research Institute (United States)

Observed institutions: Louisiana State University, Pfizer (United States), University Medical Center New Orleans, University of California System, Ferring Research Institute (United States), Louisiana State University Health Sciences Center New Orleans, University of California, Davis

OpenAlex ID: A5111925367

Isozyme-nonselective N-Substituted Bipiperidylcarboxamide Acetyl-CoA Carboxylase Inhibitors Reduce Tissue Malonyl-CoA Concentrations, Inhibit Fatty Acid Synthesis, and Increase Fatty Acid Oxidation in Cultured Cells and in Experimental Animals

2003 · H.James Harwood, Stephen F. Petras, et al. · Journal of Biological Chemistry · 243

Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TRβ subtype-selective thyromimetics

2003 · Robert L. Dow, Steven R. Schneider, et al. · Bioorganic & Medicinal Chemistry Letters · 100

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

2010 · Krystyna Tatarkiewicz, Pamela A. Smith, et al. · American Journal of Physiology-Endocrinology and Metabolism · 91

GLUT4 Overexpression in db/db Mice Dose-Dependently Ameliorates Diabetes But Is Not a Lifelong Cure

2001 · Joseph T. Brozinick, Scott C. McCoid, et al. · Diabetes · 76

PDF

Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome

2020 · Diane M. Hargrove, Sudarkodi Alagarsamy, et al. · Journal of Pharmacology and Experimental Therapeutics · 62

PDF

Discovery of Potent, Nonsteroidal, and Highly Selective Glucocorticoid Receptor Antagonists

2002 · Bradley P. Morgan, Andrew G. Swick, et al. · Journal of Medicinal Chemistry · 62

Bioluminescent imaging in induced mouse models of endometriosis reveals differences in four model variations

2021 · Ashley Dorning, Priya Dhami, et al. · Disease Models & Mechanisms · 46

PDF

Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance

2016 · Kazimierz Wiśniewski, Javier Sueiras-Diaz, et al. · Journal of Medicinal Chemistry · 41

Glucose-dependent action of glucagon-like peptide-1(7-37) in vivo during short- or long-term administration

1995 · Diane M. Hargrove, Nancy A. Nardone, et al. · Metabolism · 36

An Arginine-Deficient Diet in Humans Does Not Evoke Hyperammonemia or Orotic Aciduria

1987 · Gale P. Carey, Zane Kime, et al. · Journal of Nutrition · 36

Biological activity of AC3174, a peptide analog of exendin-4

2007 · Diane M. Hargrove, Eric S. Kendall, et al. · Regulatory Peptides · 35

Modulation of Insulin Secretion and Glycemia by Selective Inhibition of Cyclic AMP Phosphodiesterase III

1997 · Janice C. Parker, Maria A. Vanvolkenburg, et al. · Biochemical and Biophysical Research Communications · 32

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity

2010 · Richard L. Elliott, Kimberly O. Cameron, et al. · Bioorganic & Medicinal Chemistry Letters · 29

Effects of Dietary Excesses of the Branched-Chain Amino Acids on Growth, Food Intake and Plasma Amino Acid Concentrations of Kittens

1988 · Diane M. Hargrove, Quinton R. Rogers, et al. · Journal of Nutrition · 29

In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB1 receptor antagonist for the management of obesity

2010 · John R. Hadcock, David A. Griffith, et al. · Biochemical and Biophysical Research Communications · 26

Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists

2011 · David A. Griffith, Diane M. Hargrove, et al. · Bioorganic & Medicinal Chemistry Letters · 25

In Vitro and in Vivo Characterization of 3-{2-[6-(2-tert-Butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl}benzonitrile Hydrochloride Salt, a Potent and Selective NPY5 Receptor Antagonist

2003 · Richard L. Elliott, Robert M. Oliver, et al. · Journal of Medicinal Chemistry · 25

Epinephrine-induced increase in glucose turnover is diminished during sepsis

1989 · Diane M. Hargrove, Charles H. Lang, et al. · Metabolism · 25

Glucose Transport-Enhancing and Hypoglycemic Activity of 2-Methyl-2-phenoxy-3-phenylpropanoic Acids

1996 · Reinhard Sarges, Richard F. Hank, et al. · Journal of Medicinal Chemistry · 23

Leucine and isoleucine requirements of the kitten

1984 · Diane M. Hargrove, Quinton R. Rogers, et al. · British Journal Of Nutrition · 23

PDF

Discovery of potent and orally bioavailable heterocycle-based β3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity

2007 · Jennifer A. Lafontaine, Robert F. Day, et al. · Bioorganic & Medicinal Chemistry Letters · 19

Potent and selective, sulfamide-based human $beta;3-adrenergic receptor agonists

2004 · Robert L. Dow, Ernest S. Paight, et al. · Bioorganic & Medicinal Chemistry Letters · 17

Discovery of Potent, Non-Steroidal and Highly Selective Glucocorticoid Receptor Antagonists with Anti-Obesity Activity

2004 · Bradley Morgan, Kevin Liu, et al. · Letters in Drug Design & Discovery · 15

Discovery of Potent, Selective, and Short-Acting Peptidic V 2 Receptor Agonists

2019 · Kazimierz Wiśniewski, Steve Qi, et al. · Journal of Medicinal Chemistry · 13

Comparison of the glucose dependency of glucagon-like peptide-1(7–37) and glyburide in vitro and in vivo

1996 · Diane M. Hargrove, Nancy A. Nardone, et al. · Metabolism · 13

Works count: 36

Citation count: 1,185

H-index: 20

I10-index: 27